Drug Regulatory Authority
‹ Go back to expertise overview
  • Independent Monitoring, Review & Evaluation of WHO Prequalification Programme and Quality for Reproductive Health Medicines Programme

    Global

    More info
  • SADC M&E Plan for Pharmaceutical Business Plan

    South Africa, Botswana, Zimbabwe, Swaziland, Lesotho, Mozambique, Zambia, Malawi, The Democratic Republic of The Congo, Namibia, Madagascar, Angola, Mauritius, Seychelles, Tanzania

    More info
  • Planning and Value for Money Consultant (VfM) Consultant

    Myanmar (fka. Burma)

    More info
  • Preparation of a Standard Twining fiche and a Twining light fiche for the Ministry of Health of Moldova

    Moldavia

    More info
  • Final Evaluation Minisante IV

    Rwanda

    More info
  • Review of the Ethiopia Health Regulatory Agency Reform

    Ethiopia | 2016

    More info
  • the elaboration of the ToR/Strategy/Scope of work to contract PSI/MSI/MMA to work with the private sector (in MNCH but more precisely on RH).

    Myanmar (fka. Burma)

    More info
  • Development of Capacity for the procurement of Pharmaceuticals and other Health goods and services & strengthening of management capacity of the Drug Supply Company Suriname (BGVS)

    Suriname

    More info
  • Study on the viability and feasibility of BUFMAR, central medical store, Rwanda

    Rwanda

    More info
  • Total Market Analysis (Baseline and Endline) of Sexual Commodities (Condoms, sexual lubricants and other contraceptive products) in Suriname and Jamaica: free/generic, socially marketed and commercial brands

    Suriname, Jamaica

    More info